These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17766653)

  • 1. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
    Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
    Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
    Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
    Kunnimalaiyaan M; Chen H
    Oncologist; 2007 May; 12(5):535-42. PubMed ID: 17522241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo.
    Machado MC; Bellodi-Privato M; Kubrusly MS; Molan NA; Tharcisio T; de Oliveira ER; D'Albuquerque LA
    J Exp Ther Oncol; 2011; 9(2):85-92. PubMed ID: 21699015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
    Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
    Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism].
    Zhao L; Zhang ZH; Zhu CM
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):802-5. PubMed ID: 19176032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
    Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
    Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
    Xia Q; Sung J; Chowdhury W; Chen CL; Höti N; Shabbeer S; Carducci M; Rodriguez R
    Cancer Res; 2006 Jul; 66(14):7237-44. PubMed ID: 16849572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
    Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2009 Feb; 16(2):481-6. PubMed ID: 19030935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
    Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
    J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells.
    Havrda MC; Johnson MJ; O'Neill CF; Liaw L
    Thromb Haemost; 2006 Sep; 96(3):361-70. PubMed ID: 16953280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.
    Höti N; Chowdhury W; Hsieh JT; Sachs MD; Lupold SE; Rodriguez R
    Mol Ther; 2006 Dec; 14(6):768-78. PubMed ID: 16990052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.
    Wu Y; Guo SW
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo.
    Nagai H; Fujioka-Kobayashi M; Ohe G; Hara K; Takamaru N; Uchida D; Tamatani T; Fujisawa K; Miyamoto Y
    Oncol Rep; 2014 Mar; 31(3):1453-8. PubMed ID: 24398788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.
    Angelucci A; Muzi P; Cristiano L; Millimaggi D; Cimini A; Dolo V; Miano R; Vicentini C; Cerù MP; Bologna M
    Prostate; 2008 May; 68(6):588-98. PubMed ID: 18288684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch 1 signaling is active in ovarian cancer.
    Rose SL; Kunnimalaiyaan M; Drenzek J; Seiler N
    Gynecol Oncol; 2010 Apr; 117(1):130-3. PubMed ID: 20060575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.